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ABSTRACT 
Objective: To study the effects of root extract of Berberis aristata in rat model of acute hepatotoxicity induced by carbon tetrachloride (CCl4). CCL4 is 
commonly used hepatotoxin in the experimental studies of liver diseases. Liver damage induced by CCL 4 involves biotransformation of free radicals 
derivatives, increased lipid peroxidation and excessive cell death. Berberis aristata root extract, “berberine chloride” is known to possess multiple 
pharmacological activities including anti-microbial, antiviral, anti-inflammatory, cholesterol lowering, anti cancer and anti-oxidant effects. The 
present study was conducted to evaluate the hepatoprotective activity of berberine in chemical induced hepatotoxicity in rats.  
 Material & Methods: The experimental protocol was approved be the IAEC. Adult wistar rats aged 7-9 weeks were injected intraperitoneally with 
50% CCl4 as 1:1 mixture in liquid paraffin. Berberine was administered i/p before or after CCl4 treatment in various groups. Twenty-four hours after 
CCl4 injection, serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase(ALP) activities, total serum bilirubin 
levels and liver weight were measured. Histological changes of liver were examined with microscopy.  
Results: Serum ALT, AST, ALP activities significantly decreased in a dose-dependent manner in both pre-treatment and post-treatment groups with 
berberine. Histological examination showed lowered liver damage in berberine-treated groups. 
 Conclusion: The present study demonstrates that berberine possesses hepatoprotective effects against CCl4-induced hepatotoxicity and that the 
effects are both preventive and curative. Berberine should have potential for developing a new drug to treat liver toxicity.  
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INTRODUCTION 
Liver is a vital organ of metabolism and excretes virtually every drug 
and toxin introduced in the body. The global burden of liver 
disorders amount to more than 30,000 deaths annually 
[1].Hepatotoxicity is one of the main reasons behind withdrawal of a 
drug from the market. 50% of all acute liver failures and 5% of all 
hospital admissions are associated with drug-induced hepatotoxicity 
[2]. Numerous medicinal plants are being used for the treatment of 
liver disorders. In spite of tremendous strides in modern medicine, 
there is hardly any drug that offers protection to the liver from drug 
induced damage or help in regeneration of hepatic cells [3]. Many 
polyherbal formulations reputed to have hepatoprotective action are 
available in the market for liver disorders but treating a liver 
disorder by using a precise herbal drug is still an intriguing problem 
[4, 5].  
CCl4 is the most commonly used hepatotoxin in the experimental 
studies of liver diseases. Liver cell injury induced by CCl4 involves 
the metabolism of CCl4 to trichloromethyl free radical by the mixed 
function oxidase system. This leads to wide spread disturbances in 
hepatocyte function like increased lipid peroxidation and excessive 
cell death [6,7]. This model of CCl4 liver induced injury has been 
widely used in new drug development for liver diseases.Berberis 
aristata is an edible plant in South Asian traditional medicine. 
Particularly its fruit, root and stem are rich in berberine, which is 
being used as a tonic remedy for liver and heart.It is known to 
possess multiple pharmacological activities like antimicrobial, 
antiviral, anti-inflammatory, cholesterol lowering, anticancer and 
antioxidant activity [8]. The drugs having antioxidant activity are 
effective in treating CCl4 induced toxicity 
[9,10].Coptidisrhizoma(Huanglin), a popular Chinese herb, rich in 
berberine has exhibited hepatoprotective effects on CCl4 induced 
injury in a study conducted by Feng et al, 2010 [11]. Antioxidant 
effects of berberine against LDL oxidation [12] and inflammation 
have also been reported previously. Janbaz&Gilani,2000 found that 
berberine has no curative action on CCl4 induced liver injury at low 
doses; however, levels of ALT and AST were ameliorated after 
berberine   treatment   [8].    There  have been reports suggesting the  
 
habitat dependent variations in the content of berberine in the roots 
and stem-bark of Berberis species [13]. To confirm the nature and 
extent of action of berberine in Berberis asistataroot extract found in 
the Himalayan Region in India, it was necessary to do a more 
systematic and comprehensive study of hepatoprotective effects of 
berberine in CCl4 induced acute liver toxicity in rats. The present 
study aimed at exploring the preventive and curative effects of 
berberine on liver tissue injury, liver enzymes, total bilirubin and 
liver weight. 
MATERIAL AND METHODS 
STUDY CONDUCT 
The study was conducted at the Department of Pharmacology in 
collaboration with Department of Pathology and Biochemistry, 
MMInstitute of Medical Sciences &Research, Mullana, India. The 
experimental protocol was reviewed and approved by Institutional 
Animal Ethics Committee. (Ref. no.: 101/IAEC/MMIMSR/2011) 
DRUGS AND CHEMICAL REAGENTS 
Berberine chloride, CCl4, Heparin, Thiopentone sodium, 
Phenobarbitone and Liquid paraffin were obtained from Hindustan 
Pharmaceuticals, Amritsar, India. ALT, AST, ALP and Serum bilirubin 
kits were purchased from Sigma Aldrich, Bangalore, India. 
ANIMALS 
Healthy albino rats (Wistar strain) of either sex, aged 7 weeks, 
weighing 130-250 gm were obtained from Central Animal House of 
MMIMSR,Mullana. The animals were housed in the groups of 6-8 per 
cage for a minimum of 5 days prior to pharmacological experiments 
with free access to standard rodent diet with water and maintained 
on 12 hr light/ dark cycle and temperature 
(22o±3oC).Animalhousing, handling techniques and experiment 
protocols (drug treatment and sacrifice) were complied with the 
guidelines of CPCSEA, India. 
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ACUTE TOXICITY STUDIES 
The acute oral toxicity studies were performed for the root extract of 
Berberis aristata, berberine chloride, according to the OPPTS (Office 
of Prevention, Pesticide and Toxic Substance) Conventional Acute 
Toxicity Test [14].  
Animals were divided into 6 groups with 6 animals in each group: 
Group 1- Negative control (liquid paraffin, 1ml/kg, i/p) 
Group 2 - CCl4Toxic control(50% CCl4 in liquid paraffin, i/p) 
Group 3- CCl4 + Berberine 5mg/kg, i/p (post treatment) 
Group 4- CCl4 + Berberine 10mg/kg, i/p (post treatment) 
Group5- CCl4 + Berberine 20mg/kg, i/p (post treatment) 
Group 6- CCl4 + Berberine 10mg/kg, i/p (pre treatment) 
Rats from the group 2-6 were injected with CCl4 at a dose of 1ml/kg, 
i/p as a 50% liquid paraffin solution while group 1 served as a 
negative control receiving 1ml/kg, i/p of liquid paraffin only. 
Berberine was suspended in distilled water at concentration of 5,10 
and 20 mg/kg and administered i/p to rats in groups 3-5 
respectively after 6 hours of CCl4 treatment. Rats in group 6 were 
administered berberine 10mg/kg i/p twice daily for 2 days before 
CCl4 treatment. The CCl4 control group (group 2) was only 
administered with distilled water of equal volume after CCl4 toxicity. 
BLOOD SAMPLE COLLECTION 
24 hours after CCl4 treatment, the animals were anaesthetized using 
thiopentone sodium, 40mg/kg, i/p. Blood samples were collected by 
cardiac puncture in sterilized dry centrifuge tube and allowed to 
coagulate for 30 mins at 37 ºC. The serum was separated at 2500 
rpm (micro centrifuge) for 10 mins and subjected to biochemical 
investigations viz. aspartate aminotransferase (AST), alanine 
aminotransferase  (ALT), alkaline phosphatase (ALP) and total 
bilirubin (TB). 
ASSESSMENT OF LIVER FUNCTION 
The AST, ALT, ALP activities in serum sample were analyzed by 
using Chemistry Auto Analyzer (RT 1904C). The values were 
expressed in terms ofInternational Units/litre (IU/L). 
HISTOPATHOLOGICAL ANALYSIS 
Immediately after blood collection the animals were sacrificed by an 
overdose of phenobarbitone 200 mg/kg, i/p. The liver of each rat 
was promptly removed and fixed in 10% formaldehyde solution for 
at least 24 hours before histopathological study. Samples were then 
embedded in paraffin wax and thin sections were stained with 
hematoxylin and eosin (H&E) and mounted on glass slides. The 
degree of liver damage was estimated under light microscope and 
images were captured with Nikon Pentahead Microscope (ECLIPSE 
80i, Y-THR-L, Japan) at original magnification of 210 X. 
STATISTICAL ANALYSIS 
The data were analyzed with the help of computer software SPSS 
version 16 for windows. All data are expressed as mean ± SEM. The 
results were inferred by one-way analysis of variance (ANOVA) test 
followed by histopathological analysis. For multiple group 
comparison, Fisher’s LSD test was used. P values (two tailed) <0.05*  
&<0.001** were considered statistically significant and highly 
significant respectively. 
RESULTS  
Effects of berberine on AST, ALT, ALP and T. bilirubin levels in rats 
from various treatment groups are shown in Table 1 as below: 
 
Values are expressed as mean ± SEM for albino rats in each 
group. P values: *<0.05, **<0.01, when compared with control 
group 
The serum levels of AST, ALT, ALP and T. bilirubin were significantly 
increased (p<0.01) in CCl4 treated group 2 rats. Group 3-5 rats 
treatedwith CCl4 followed by berberine chloride at doses of 5, 10 and 
20 mg/kg, i/p respectively showed significantdecrease (p<0.05) in 
AST, ALT, ALP and T. bilirubin levels when compared to group 2 rats. 
The CCl4 (1ml/kg, i/p) intoxication elevated levels of serum 
biochemical parameters: AST(529.39±86.13), ALT(502.56±47.03), 
ALP (293.84±32.37), T. bilirubin (0.81±0.06). The total liver weight 
was also increased significantly (2.54±0.11, p<0.05) indicating acute 
hepatocellular damage and fatty degeneration. 
When compared with CCl4 toxic control group, the groups post 
treated with berberine chloride at doses of 5,10 and 20 mg/kg, i/p in 
CCl4 intoxicated rats exhibited significant reduction of 
AST(343.11±175.70,70.27±20.33, 37.27±16.90), ALT 
(250.65±25.34,65.11±7.63,41.35±6.47), 
ALP(200.83±32.20,81.28±15.03,48.88±6.04) and T.bilirubin 
(0.74±0.09,0.38±0.10, 0.23±0.03) levels and liver weight 
(2.38±0.08,2.22±0.01,2.03±0.05), (p<0.005). Hence, the activities of 
the liver enzymes in berberine post treated groups of low dose, 
medium dose and high dose decreased significantly in a dose 
dependent manner(AST:F=39.43, p<0.05;ALT:F=72.52, p<0.05;ALP: 
F=25.17, p<0.05) when compared with CCl4 toxic control group. The 
high dose (20mg/kg) of berberine suppressed the AST,ALT, ALP and 
T.bilirubin levels to lower than normal levels as in group 1 (table1). 
The effects of Berberine pretreatment on enzyme levels,T. bilirubin 
and liver weight show that, at dose of 10 mg/kg, the extract could 
offer significant degree of protection against CCl4 induced 
hepatotoxicity. The serum levels of AST,ALT,ALP and T. bilirubin 
decreased to 57.61±18.80,52.32±6.69,62.69±13.07 and 0.28±0.06 
respectively as compared to CCl4 toxic control group. The liver 
weight also remained with in the normal limits indicating the 
preventive action of Berberine.The results shown by the pre 
treatment group are comparable to the results with the medium 
dose of Berberine post treatment group and are statistically 
significant (p<0.05 in both groups). 
The efficacy of extract was tested for its hepatoprotective activity, 
the relationship between dose and percentage reduction in each 
case has been shown in Fig 2a as below: 
Treatment Group 
(n=6)
Biochemical parameters   (mean S.E.M)
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* 0.38          
 0.10
* 2.22          
 0.015
BC20mg+CCl4
* 37.277         
 16.90
* 41.3586      
 6.47 
* 48.886        
 6.04
* 0.23             
 0.03
* 2.0329         
 0.05
PRE BC10+CCl4
* 57.61           
18.80 
* 52.3267      
 6.69
* 62.695         
 13.07
* 0.2883         
 0.06
2.2717         
 0.13
* p-value <0.05 significant in comparison to Control Group(Fisher LSD)
One -way ANOVA
F=39.438                      
Df 30,5                           
P=.000*
F=72.524                        
Df 30,5                          
P=.000*
F=25.178                      
Df 30,5                        
P=.000*
F=15.544                     
Df 30,5                          
P=.000*
F=5.092                       
Df 30,5                         
P=.002*
Table:1 Effects of Berberine chloride on Chemical induced Acute 
Hepatotoxicity in rats
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Figure 2a: shows effect of Berberine chloride on biochemical 
estimation of AST, ALT, ALP, T. bilirubin & liver weight and 
percentage reduction in various parameters after treatment 
with different doses 
The percentage reduction of various biochemical parameters after 
treatment with berberine also showed significant results (p<0.05) in 
AST (35%, 86%, 93%), ALT (50%, 87%, 91%), ALP (32%, 72%, 83), 
T. bilirubin (90%, 53%, 72%) and liver weight reduced to 6%, 
12%and 20%. 
HISTOPATHOLOGY 
The results from the histopathological studies of liver sections in 
various groups are in agreement with the observed serum levels of 
biochemical parameters. 
Group 1-(Liquid paraffin- control, Fig 1) Section shows central veins 
with radiating chords of hepatocytes (normal architecture) 
Group 2-(CCl4 Toxic control, Fig 2) Section shows macro vesicular 
fatty change around central vein and large areas of necrosis with 
inflammation. 
Group 3-(Berberine chloride-5 mg/kg +CCl4, Fig 3) section 
showsleaky hepatocytes, macrovesicular fatty change 
Group 4-(Berberine chloride-10 mg/kg +CCl4, Fig 4) section 
showslymphomononuclear cell infiltrate in periportal and 
centrilobular areas as well as scattered in hepatic parenchyma with 
few cells showing feathery degeneration with significantly dilated 
and congested sinusoids. 
Group 5-(Berberine chloride-20mg/kg +CCl4, Fig 5) section 
showspresence of normal hepatic cords, absence of necrosis and 
macrovesicular fatty change (near normal architecture) 
Group 6-(Pre- Berberine chloride 10 mg+CCl4, Fig 6) section shows 
normal hepatic architecture, nearly similar to that of healthy control 
with very mild hepatic steatosis. 
Figure 1-6: show representative photographs of histopathological changes showing the effects of berberine chloride at different doses on 
liver tissue of CCL4 intoxicated rats 
Hepatic tissue changes were improved in the histopathology 
sections in berberine post and pre treated rats as compared to the 
toxic control group.The above results indicate the curative and 
preventive effect of berberine against CCl4 induced acute liver 
damage in dose dependent manner. 
DISCUSSION 
The aqueous root extract of Berberis aristata showed good 
hepatoprotective activity when administered at doses of 10mg/kg 
and 20 mg/kg; i/p and the effects were dose dependent. The effects 
produced by the pre-treatment dose of 10mg/kg were similar to that 
produced by post treatment 10mg/kg dose as evidenced by the 
decreased serum enzyme levels and T. bilirubin (Tab 1, Fig 1).These 
results were confirmed by the histopathological changes in the 
section of the liver (Fig 2 to Fig 6).Drugs are an important cause of 
liver injury and account for 75% of the liver disease induced 
mortality and morbidity. The drug-induced liver injures range from 
asymptomatic elevation of liver enzymes to necrosis, fatty 
degeneration and fulminant hepatic failure [1,2]. Drugs having anti 
oxidant activity are effective in treating CCl4 induced hepatotoxicity 
Figure 1: Negative control- Liquid Paraffin Figure 2: CCl4   Toxic Control 
Figure 3: Berberine chloride(5 mg/kg)  + CCl4 
Figure 4: Berberine chloride(10 mg/kg) + CCL4 	
Figure 6: Pre-Berberine chloride(10 mg/kg) + CCL4 	Figure 5: Berberine chloride(20 mg/kg) + CCL4 	
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[15]. The root extract of Berberis aristatais known to have anti 
oxidant activity [6,7]. The CCl4 induced significant increase in liver 
enzymes and T.bilirubin levels. Liver weight was increased due to 
blocking of secretion of hepatic TGs into plasma[16]. Medium and 
high dosepost-treatment of the extract cured the increased liver 
enzyme levels and liver weight in group 2-5 rats and in group 6, pre-
treatment with 10mg/kg berberine chloride prevented further 
increase in liver enzymes and liver weight. Thus, the results 
presented in our study are in agreement with the previous study 
conducted by the Feng et al, 2010 on berberine extracted from a 
Chinese herb, Coptidisrhizome. However, the study conducted by 
Janbaz and Gilani reported that low doses of berberine exhibit no 
effect in reducing hepatic damage but in our study the lower doses 
of berberine (5mg/kg, i/p) produced a significant reduction in the 
biochemical parameters and offered protection to liver tissue. In 
addition, the histological changes in the rat liver sections post-
treated with berberine showed reduced incidence of liver necrosis, 
fatty degeneration,leukocyte infiltration induced by CCl4 (Fig 2 to 6). 
There are reports about the habitat dependent variations in the 
Berberine content of Berberis species found in the North Himalayan 
region of India [11]. Due to the discrepancies observed in the actions 
of the extract at different doses, this study was planned to explore 
more about the actions of the Berberis species found in India. The 
present study found that Berberine has both preventive and curative 
effects againstCCl4 induced liver injury. Additionally, the habitat 
might have played role in the potency of the extract at a particular 
dose as lowest dose of 5 mg/kg, i/p could produce significant 
reduction in serum enzyme and T. bilirubin levels. 
CONCLUSION 
In conclusion, the root extract of Berberis aristata showed good 
hepatoprotective activity against CCl4 induced acute liver damage. 
The effects are both preventive and curative in nature and were 
further endorsed by the histopathological changes in the liver. 
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